Volume XX No. 3 – March 4, 2013
In this issue:
A NEW YORK HOSPITAL LABORATORY introduced algorithms to screen for the presence of are methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile (C. diff), probably the most challenging infections for hospitals to control and reduce. And in the past five years, the hospital not only cut costs by almost $3 million and improved quality, but also did fewer tests for these two infectious diseases. The contribution of this lab demonstrates how labs can leverage lab testing to deliver increased value.